RT info:eu-repo/semantics/article
T1 Enfermedad de alzheimer. Nuevos criterios diagnósticos e implicaciones en la práctica clínica.
A1 Rojo Martínez, Esther
A2 Ediciones Universidad de Valladolid
AB The progress made in recent years in research on Alzheimer's disease (AD) have necessitated a change in the diagnostic criteria of this disease. Therefore, in 2011 the new diagnostics for AD and mild cognitive impairment (MCI) due to Alzheimer criteria proposed by the National Institute on Aging and the Alzheimer's Association (NIA-AA) were published. These new criteria emphasize that the pathophysiological process of AD begins several years before the first clinical symptoms appear and propose the use of biomarkers able to predict progression to AD in preclinical stages, and to support the diagnosis in phases of MCI or dementia. Although most biomarkers currently are being used for research purposes, it is likely that in the near future are also available in clinical practice. The number of patients with EA continues to grow in a population such as ours increasingly aging; therefore, in this manner, these new criteria aim to make an early diagnosis of AD that allows establishing treatments capable of modifying the course of disease when available.
SN 0210-6523
YR 2014
FD 2014
LK http://uvadoc.uva.es/handle/10324/23857
UL http://uvadoc.uva.es/handle/10324/23857
LA spa
NO Anales de la Real Academia de Medicina y Cirugía de Valladolid, 2014, N.51, pags.67-76
DS UVaDOC
RD 26-ene-2025